The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 11 2020
11 11 2020
Historique:
received:
29
01
2020
accepted:
24
09
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
23
4
2021
Statut:
epublish
Résumé
Epstein-Barr virus (EBV) reactivation can lead to serious complications in kidney transplant patients, including post-transplant lymphoproliferative disorder (PTLD). Here, we have assessed the impact of EBV on B cell homeostasis at cellular and humoral level. In a multicenter study monitoring 540 kidney transplant patients during the first post-transplant year, EBV reactivation was detected in 109 patients. Thirteen soluble factors and B cell counts were analyzed in an EBV
Identifiants
pubmed: 33177622
doi: 10.1038/s41598-020-76607-z
pii: 10.1038/s41598-020-76607-z
pmc: PMC7658229
doi:
Substances chimiques
B-Cell Activating Factor
0
TNFSF13B protein, human
0
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19594Références
Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15
pubmed: 23684423
N Engl J Med. 2018 Feb 8;378(6):549-562
pubmed: 29414277
Br J Haematol. 2003 Sep;122(6):927-33
pubmed: 12956763
Molecules. 2019 Mar 12;24(5):
pubmed: 30871092
Sci Signal. 2016 Jan 12;9(410):ra4
pubmed: 26758212
J Immunol. 2005 Sep 1;175(5):2814-24
pubmed: 16116167
PLoS One. 2015 Sep 09;10(9):e0137503
pubmed: 26352148
Front Immunol. 2016 Aug 23;7:319
pubmed: 27602031
Transplant Direct. 2015 Dec 15;2(1):e48
pubmed: 27500242
Cancer Lett. 2015 Dec 1;369(1):37-44
pubmed: 26279520
Transplant Direct. 2018 May 15;4(6):e353
pubmed: 30123826
Blood. 2002 Jun 15;99(12):4364-9
pubmed: 12036863
Front Physiol. 2019 Apr 17;10:402
pubmed: 31057415
Oral Dis. 2018 May;24(4):497-508
pubmed: 28190296
Br J Cancer. 2009 Sep 15;101(6):1019-27
pubmed: 19738620
Sci Transl Med. 2018 Aug 1;10(452):
pubmed: 30068569
Front Immunol. 2018 Jun 07;9:1285
pubmed: 29930556
Front Microbiol. 2019 Jul 12;10:1544
pubmed: 31354653
Adv Anat Pathol. 2009 Jan;16(1):40-55
pubmed: 19098466
Immunology. 2006 Aug;118(4):497-508
pubmed: 16895557
AIDS. 2018 Apr 24;32(7):945-954
pubmed: 29424776
Integr Biol (Camb). 2012 Dec;4(12):1478-86
pubmed: 23080410
Int J Epidemiol. 2017 Apr 1;46(2):746-755
pubmed: 28025257
EBioMedicine. 2018 Aug;34:113-121
pubmed: 30072213
J Neuropathol Exp Neurol. 2010 Jul;69(7):677-93
pubmed: 20535037
Science. 1999 Jul 9;285(5425):260-3
pubmed: 10398604
J Exp Med. 1999 Aug 16;190(4):567-76
pubmed: 10449527
Clin Dev Immunol. 2013;2013:150835
pubmed: 23690819
Semin Immunol. 2014 Jun;26(3):191-202
pubmed: 24996229
Am J Transplant. 2013 Mar;13(3):656-62
pubmed: 23331474
Transplantation. 2007 Aug 15;84(3):387-91
pubmed: 17700165
Transpl Int. 2011 Sep;24(9):892-903
pubmed: 21668529
N Engl J Med. 2004 Mar 25;350(13):1328-37
pubmed: 15044644
Microorganisms. 2019 Jun 24;7(6):
pubmed: 31238570
J Immunol. 2003 Nov 15;171(10):5215-24
pubmed: 14607922
Lancet. 2017 Dec 17;388(10063):3006-3016
pubmed: 27871759
Transplantation. 2009 Jul 15;88(1):89-95
pubmed: 19584686
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Front Immunol. 2019 May 28;10:1148
pubmed: 31191530
Cytokine. 2013 Sep;63(3):237-40
pubmed: 23693158
Pathol Oncol Res. 2011 Sep;17(3):443-54
pubmed: 21193979
Am J Transplant. 2008 May;8(5):1016-24
pubmed: 18312608